首页> 外国专利> METHODS OF TREATING CARDIOMYOPATHY, SYSTOLIC CARDIAC DYSFUNCTION AND THE SYMPTOMS OF CONGESTIVE HEART FAILURE WITH PROBENECID

METHODS OF TREATING CARDIOMYOPATHY, SYSTOLIC CARDIAC DYSFUNCTION AND THE SYMPTOMS OF CONGESTIVE HEART FAILURE WITH PROBENECID

机译:伴有坏死病的心律失常,收缩期心脏功能障碍和充血性心力衰竭症状的治疗方法

摘要

Described herein are inventions is directed to methods of treating a cardiac dysfunction and symptoms of cardiac dysfunction in a subject that includes administering an amount of probenecid effective to treat a symptom of cardiac dysfunction. The probenecid may be administered in at least one of an injection, orally, or transdermally. The amount of probenecid is sufficient to result in an improved performance on a standardized 6 minute walk test, an improved New York Heart Association (NYHA) classification, a lower diuretic dose requirement, a lower serum BNP levels, a normalization of serum sodium concentrations, and combinations thereof In an embodiment, probenecid is administered over a period of about 8 hours to about 24 hours. Probenecid may be used for short term treatments, i.e., less than a week, or it may be administered in a long term manner, i.e., over a period of weeks, months, or even years. Probenecid may be administered in an amount sufficient to treat the symptoms of cardiac dysfunction.
机译:本文描述的发明是针对在受试者中治疗心脏功能障碍和心脏功能障碍的症状的方法,其包括施用有效治疗心脏功能障碍的症状的丙磺舒的量。丙磺舒可通过注射中的至少一种口服或透皮给药。丙磺舒的量足以在标准的6分钟步行测试中改善性能,改善纽约心脏协会(NYHA)分类,降低利尿剂剂量要求,降低血清BNP水平,使血清钠浓度正常化,在一个实施方案中,丙磺舒在约8小时至约24小时的时间内施用。丙磺舒可以用于短期治疗,即少于一周,或者可以长期施用,即在数周,数月甚至数年的时间内施用。丙磺舒可以以足以治疗心脏功能障碍症状的量给药。

著录项

  • 公开/公告号US2013046021A1

    专利类型

  • 公开/公告日2013-02-21

    原文格式PDF

  • 申请/专利权人 JACK RUBINSTEIN;W. KEITH JONES;

    申请/专利号US201213584713

  • 发明设计人 JACK RUBINSTEIN;W. KEITH JONES;

    申请日2012-08-13

  • 分类号A61K31/195;A61P9/04;A61P9;

  • 国家 US

  • 入库时间 2022-08-21 16:49:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号